PTC Therapeutics to Participate at Upcoming Investor Conferences
Rhea-AI Summary
PTC Therapeutics (NASDAQ: PTCT) has announced its participation in four major healthcare investor conferences in May and June 2025. The schedule includes:
- Bank of America Securities Healthcare Conference on May 13 at 1:00 p.m. ET
- RBC Capital Markets Global Healthcare Conference on May 20 at 2:05 p.m. ET
- William Blair 45th Annual Growth Stock Conference on June 3 at 10:20 a.m. ET
- Goldman Sachs 46th Annual Global Healthcare Conference on June 10 at 9:20 a.m. ET
All presentations will be available via live webcast on PTC's investor relations website and will remain accessible for 30 days after each event. Viewers are advised to connect several minutes before the start time.
Positive
- None.
Negative
- None.
News Market Reaction – PTCT
On the day this news was published, PTCT declined 0.80%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Bank of America Securities 2025 Health Care Conference
Tuesday, May 13 at 10:00 a.m. PT / 1:00 p.m. ET
RBC Capital Markets Global Healthcare Conference 2025
Tuesday, May 20 at 2:05 p.m. ET
William Blair 45th Annual Growth Stock Conference 2025
Tuesday, June 3 at 9:20 a.m. CT / 10:20 a.m. ET
Goldman Sachs 46th Annual Global Healthcare Conference 2025
Tuesday, June 10 at 9:20 a.m. ET
The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, X, and LinkedIn.
For More Information:
Investors:
Ellen Cavaleri
+1 (615) 618-6228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-302436290.html
SOURCE PTC Therapeutics, Inc.